All News

In each trial, overall response rate and median progression-free survival in the novel treatment arm showed significant improvement over the sunitinib treatment arm in patients with renal cell carcinoma.

Lakesha M. Butler, PharmD, BCPS, diversity and inclusion coordinator and clinical professor at Southern Illinois University Edwardsville, discussed causes of health inequity and how pharmacists can prevent and mitigate them to improve patient outcomes.

A drug recycling program can help increase patient access and minimize waste of expensive oral cancer medications.

Promising investigational oncology drugs include oral taxanes, small molecule drugs, and immunotherapies.

Common factors that contributed to reported increased dissatisfaction at work include role conflict, quantity of work, workflow disruptions, organizational culture, and leadership support.

Even while therapeutically anticoagulated, patients with cancer have risk factors for recurring venous thromboembolism and bleeding, according to a session at the Hematology/Oncology Pharmacy Association 2021 Virtual Annual Conference.

Research is the first to link chronic sinus inflammation with a neurobiological change.

Heart failure and stroke are rising among individuals below 40 years of age, with links between obesity and low fitness in the late teen years and these early diagnoses.

Errors related to extended-release opioids and COVID-19 vaccines warrant attention and should be a priority.

A session at the Hematology/Oncology Pharmacy Association Virtual Annual Conference provided an overview of how treatment options are changing with potential new therapies in development for patients with non-small cell lung cancer.

Nearly half of independent pharmacists surveyed by the National Community Pharmacists Association are not getting enough or any doses of the COVID-19 vaccine.

Pharmacists can play an integral role when it comes to the management of diabetes, whether by educating patients on lifestyle changes, medications, or disease state management.

Because each of these methods targets 1 of 2 subtypes of tumor cell, both methods must be utilized simultaneously in order to kill the majority of the tumor mass, according to the study.

From countless hours of studying to participating in pharmacy organizations to volunteering in the community, it’s no surprise that student pharmacists often struggle to find balance as a well-rounded student.

The Association of Community Cancer Centers (ACCC) Oncology Pharmacy Education Network (OPEN) provides resources that are pharmacist driven and developed.

As the FDA and CDC have paused use of the Johnson & Johnson COVID-19 vaccine in the United States, research is ongoing to understand whether cerebral venous sinus thrombosis (CVST) is directly linked to the vaccine.

During the initial CAR T-cell therapy period, the total cost of care ranged from $350,000 to more than $2 million.

A study comparing the efficacy of the 2 commercially available herpes zoster (HZ) vaccines, the live zoster vaccine and the non-live recombinant zoster vaccine, found that RZV has both higher efficacy and broader use cases, according to the authors.

The safety profile was consistent with the profiles associated with each drug as a monotherapy, with no clinically significant drug-drug interactions observed with the combination.

The FDA and CDC said that 6 women experienced cerebral venous thrombosis, an extremely rare disorder associated with blood clotting, 6 to 16 days after the Johnson & Johnson COVID-19 vaccine was administered.

Pharmacists may provide nutritional counseling regarding dietary adjustments or recommendations for over-the-counter supplements to assist patient with cancer.

A presentation at the Community Oncology Alliance 2021 Virtual Conference focused on the latest developments in gastrointestinal oncology and how the field of gastroesophageal cancer is responding to 3 major, practice-changing trials.

For the future of precision medicine, many health care providers hope to see a flood of new therapies for biomarker testing to be approved in the next few months.

In a presentation at the Community Oncology Alliance 2021 Virtual Conference, Jeff Sharman, MD, summarized the most important developments in care for CLL.

A survey shows that 13% of respondents started or increased substance use to cope with pandemic-related stress or emotions.

Over the past 18 months, the FDA has approved 4 new regimens for HER2-positive metastatic disease.

The data were presented for the first time at the virtual 2021 American Association for Cancer Research (AACR) Annual Meeting, April 10-15, 2021.

The pharmacist is the last barrier between a patient and a drug, which is why it's critical for pharmacists to check for allergies, potential drug interactions, patient understanding of how to use the drug, and whether the prescription is appropriate for the diagnosis.